Efficacy matters: broadening complement inhibition in COVID-19.

Mastellos, Dimitrios C; Skendros, Panagiotis; Calado, Rodrigo T; Risitano, Antonio M; Lambris, John D

Mastellos, Dimitrios C; Skendros, Panagiotis; Calado, Rodrigo T; Risitano, Antonio M; Lambris, John D.

Mastellos DC; Division of Biodiagnostic Sciences and Technologies, INRASTES, National Center for Scientific Research "Demokritos", Athens, Greece.
Skendros P; First Department of Internal Medicine and Laboratory of Molecular Hematology, University Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece.
Calado RT; Department of Medical Imaging, Hematology and Clinical Oncology, Ribeirão Preto School of Medicine, University of São Paulo, Ribeirão Preto, Brazil.
Risitano AM; Department of Clinical Medicine and Surgery, Federico II University of Naples, Naples, Italy.
Lambris JD; Hematology and Hematopoietic Stem Cell Transplantation Unit, AORN San Giuseppe Moscati, Avellino, Italy.

Lancet Rheumatol ; 3(2): e95, 2021 Feb.

Article in English | MEDLINE | ID: covidwho-974808

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Lancet Rheumatol Year: 2021 Document Type: Article Affiliation country: S2665-9913(20)30423-9

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google